Displaying 49 - 60 of 67
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

IMP: Shining a spotlight on obesity treatment in NAFLD/NASH - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

IMP: Shining a spotlight on obesity treatment in NAFLD/NASH - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

IMP: Shining a spotlight on obesity treatment in NAFLD/NASH - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

IMP: Shining a spotlight on obesity treatment in NAFLD/NASH - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

IMP: Shining a spotlight on obesity treatment in NAFLD/NASH - ILC 2021

View
Displaying 49 - 60 of 67